Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.6860
+0.0470 (7.36%)
At close: Aug 13, 2025, 4:00 PM
0.6847
-0.0013 (-0.19%)
After-hours: Aug 13, 2025, 6:03 PM EDT
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $57.11 million as of August 13, 2025. Its market cap has decreased by -56.29% in one year.
Market Cap
57.11M
Enterprise Value
-56.41M
1-Year Change
-56.29%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $57.11M, a decrease of -81.07%. That is a compound annual growth rate of -28.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 53.20M | -32.89% |
| Dec 31, 2024 | 79.27M | -2.83% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | 275.39M | -8.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |